The Impact of Systematic Laparoscopic Skills and Suture Training on Laparoscopic Hysterectomy Outcomes in a Brazilian Teaching Hospital by Anna Luiza Lobão Gonçalves (8401041)

“…The main indication for TLH was uterine myoma (66.4%). Group I-3 presented a decrease in surgical time compared to group I-2 (p=0.010). …”

A close-up shot of protein-protein docking, from experiment to theory and reverse with the PROTAC performers by Khanh Quynh Thi Nguyen (17865389)

“…This resulted in a significant decrease in the mean RMSD value from 31.8 and 31.0 Å to 24.4 Å, respectively. …”

Association between NOx exposure and deaths caused by respiratory diseases in a medium-sized Brazilian city by A. C. G. César (6510392)

“…A 3 µg/m3 reduction in NOx concentration resulted in a decrease of 10-18 percentage points in risk of death caused by respiratory diseases. …”

The Efficacy and Safety of Current Treatments in Diabetic Macular Edema: A Systematic Review and Network Meta-Analysis by Lu Zhang (50563)

“…Combined intravitreal triamcinolone with LASER has a stronger efficacy in decreasing CMT than the other interventions in the early stage after injection. …”

Trajectory comparison in the map of Fig 17a for the unclustered, clustering, bygone, exterior and iterative strategies. by Vinícius Antonio Battagello (8939330)

Table1_Glucose Metabolism Reprogramming of Regulatory T Cells in Concanavalin A-Induced Hepatitis.DOCX by Chen Huang (202847)

“…Moreover, enhanced glycolysis and reduced OXPHOS were found in Tregs from EAH model mice, as reflected by elevated levels of key glycolytic enzymes (HK2, PK-M2, and LDH-A) and a decreased ATP concentration. This study revealed a decreased peripheral Treg frequency and abnormal intrahepatic Treg infiltration in AIH. …”

A hypothetical schematic diagram showing molecular events occurs during hypobaric hypoxia in kidney. by Varun Chhabra (5513573)

Supplementary Figures from A Metastatic Mouse Model Identifies Genes That Regulate Neuroblastoma Metastasis by Bo Kyung A. Seong (14926620)

“…Supplementary Figure 4 - CADM1 over-expression decreases migration of SHEP cell line. Supplementary Figure 5 - Verteporfin (VP), a pharmacological inhibitor of YAP, induces apoptosis and decreases migration of metastatic cells in in vitro and inhibits the metastatic phenotype in vivo. …”

Effects of huperzine A on hippocampal inflammatory response and neurotrophic factors in aged rats after anesthesia by Yi Cai (233861)

“…Conclusion HupA may alleviate the cognitive impairment in rats after isoflurane anesthesia by decreasing inflammatory factors and increasing hippocampal neurotrophic factors in hippocampus tissue.…”

Calibrated curve assuming a normal distribution, using bchron in R, and histogram of temple dates. by Sarah Klassen (5931605)

Image_1_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.TIF by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Table_7_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.DOCX by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Image_3_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.TIF by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Table_1_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.DOCX by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Table_8_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.DOCX by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Table_2_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.DOCX by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Table_4_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.DOCX by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Image_2_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.TIF by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Table_6_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.DOCX by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Table_3_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.DOCX by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”